Acne Formula (Fen Ci Fang) (ChinaHerb)
R223.00
Acne Formula uses nourishing Kidney and Yin herbs to balance Yin and Yang while clearing Deficiency Fire and a combination of clearing Damp–Heat herbs to clear facial or spine papules. Chinese medicine believes that the body is developing during adolescence. The physique is full of Yang and the Lungs and Stomach are prone to Heat and Dampness due to stress or improper diet. Damp and Heat tangled together and forms pimples and cyst nodules on the face, shoulders, chest or back, forming acne. The Acne Formula is recommended for addressing the symptoms of acne and skin pimples.
Availability: In stock
Best before: 2024-04-30
60 tablets
Ingredients:
Each tablet contains:
Artemisia scoparia herb (Yin Chen) 256mg
Rehmannia glutinosa rhizome preparata (Shu Di) 204.8mg
Cornus officinalis fruit (Shan Zhu Yu) 128mg
Dioscorea opposita rhizome (Shan Yao) 128mg
Alisma orientalis root (Ze Xie) 102.4mg
Paeonia suffruticosa bark (Mu Dan Pi) 128mg
Anemarrhena asphodeloides rhizome (Zhi Mu) 128mg
Phellodendron amurense bark (Huang Bai) 128mg
Poria cocos (Fu Ling) 76.8mg
- Pure herbal product
- No animal ingredients
Directions to use: Adults: Take 2 (two) tablets 2 (two) times a day 30 minutes before or after meals or as directed by a Tradidional Chinese Medicine practitioner.
Did you know?
Acne is the most common skin disease globally. It is primarily a hormone-related condition of the sebaceous glands which occurs mainly in adolescents during puberty and has various degrees of severity. Common acne symptoms are oily skin with pimples, pustules and blackheads that develop over time and persist, unlike normal pimples. They can also leave small red spots or scars. Acne occurs mainly on areas of the body with a particularly large number of sebaceous glands, such as the face, chest, neck, upper arms and back.
Disclaimer: This unregistered medicine has not been evaluated by the SAHPRA for its quality, safety or intended use.
You must be logged in to post a review.
Reviews
There are no reviews yet.